Form 4: Recursion Pharmaceuticals Director Borgeson Receives Stock Grants
SEC Form 4
Director Blake Borgeson receives stock options and restricted stock units from Recursion Pharmaceuticals.
Summary
- On June 3, 2024, Blake Borgeson, a director at Recursion Pharmaceuticals, received a grant of 13,097 Class A Common Stock restricted stock units.
- These restricted stock units will vest on the earlier of June 3, 2025, or the day prior to the Issuer's 2025 annual meeting of stockholders, contingent upon continued service to the Issuer.
- Borgeson also acquired a stock option (Right to Buy) for 26,193 shares at an exercise price of $8.59 on the same date.
- These options will vest and become exercisable on the earlier of June 3, 2025, or the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to continued service.
- Following these transactions, Borgeson beneficially owns 7,200,010 shares of Class A Common Stock and 26,193 derivative securities.
Sentiment
Score: 7
Explanation: The document reflects a routine grant of stock options and restricted stock units to a director, which is generally viewed positively as it aligns management interests with shareholders. There are no indications of negative news or concerns.
Positives
- The grant of restricted stock units and stock options to a director aligns their interests with the company's long-term success.
- The vesting schedules tied to continued service incentivize the director to remain with the company.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedules of the granted securities.
Industry Context
Stock grants and options are common forms of compensation for directors in publicly traded companies, aligning their interests with shareholders and incentivizing long-term value creation.
Stakeholder Impact
- The stock grants may have a minor dilutive effect on existing shareholders.
- The grants incentivize the director to contribute to the company's success, potentially benefiting all stakeholders.
Key Dates
| Date | Description |
|---|---|
| 06/03/2024 | Date of transaction: Grant of restricted stock units and stock options. |
| 06/03/2025 | Earliest vesting date for restricted stock units and stock options. |
| 06/05/2024 | Date of signature by attorney-in-fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.